The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke

Trials

Volumn 12, Issue , 2011, Pages

  Kent, David M ^a   Thaler, David E ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CRYPTOGENIC STROKE; ECHOCARDIOGRAPHY; ENDOVASCULAR SURGERY; MATHEMATICAL MODEL; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PREDICTOR VARIABLE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; STROKE; DATA BASE; DECISION SUPPORT SYSTEM; HEART CATHETERIZATION; HUMAN; METHODOLOGY; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME;

DATABASES AS TOPIC; DECISION SUPPORT TECHNIQUES; EMBOLISM, PARADOXICAL; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; LOGISTIC MODELS; MODELS, STATISTICAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 79960696120     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-185     Document Type: Article

References (34)

1. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989, 25:382-390. 10.1002/ana.410250410, 2712533.
2. Patten BM. The closure of the foramen ovale. Am J Anat 1931, 48:19-44.
3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984, 59:17-20.
4. Homma S, Sacco RL. Patent foramen ovale and stroke. Circulation 2005, 112:1063-1072. 10.1161/CIRCULATIONAHA.104.524371, 16103257.
5. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, . Patent Foramen Ovale and Atrial Septal Aneurysm Study Group Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. New England Journal of Medicine 2001, 345:1740-1746. 10.1056/NEJMoa011503, 11742048, Patent Foramen Ovale and Atrial Septal Aneurysm Study Group.
6. DiTullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992, 117:461-465.
7. Alsheikh-Ali AA, Thaler DE, Kent DM. Patent Foramen Ovale in Cryptogenic Stroke. Incidental or Pathogenic?. Stroke 2009,
8. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007, 357:2262-2268. 10.1056/NEJMoa071422, 18046029.
9. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000, 55:1172-1179.
10. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 2009, 73:89-97. 10.1212/WNL.0b013e3181aa2a19, 19439720.
11. Kent DM, Thaler DE. Is patent foramen ovale a modifiable risk factor for stroke recurrence?. Stroke 2010, 41:S26-S30. 10.1161/STROKEAHA.110.595140, 20876498.
12. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials 2010, 11:85. 10.1186/1745-6215-11-85, 2928211, 20704705.
13. Kent DM, Hayward RA. When averages hide individual differences in clinical trials. American Scientist 2007, 95:60-68.
14. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. Lancet 1999, 353:2105-2110. 10.1016/S0140-6736(98)11415-0, 10382694.
15. Thaler DE, Kent DM. Rethinking trial strategies for stroke and patent foramen ovale. Curr Opin Neurol 2010, 23:73-78. 10.1097/WCO.0b013e3283352dbc, 2865205, 20050353.
16. Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA 2007, 298:1209-1212. 10.1001/jama.298.10.1209, 17848656.
17. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet 2005, 365:256-265.
18. Schmid CH, Landa M, Jafar TH, Giatras I, Karim T, Reddy M, Stark PC, Levey AS. Constructing a database of individual clinical trials for longitudinal analysis. Control Clin Trials 2003, 24:324-340. 10.1016/S0197-2456(02)00319-7, 12757997.
19. Selker H, Griffith J, Beshansky J, Califf RM, D'Agostino RB, Laks MM, Lee K, Maynard C, Wagner GS, Weaver WD. The thrombolytic predictive instrument (TPI) project: combining clinical study databases to take medical effectiveness to the streets. DHHS 1992, 9-31.
20. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41. 10.1161/01.STR.24.1.35, 7678184.
21. Kent DM, Trikalinos TA, Thaler DE. Patent foramen ovale and cryptogenic stroke. N Engl J Med 2008, 358:1519-1520.
22. Hastie T, Tibshirani R. Generalized additive models. Statistical Science 1986, 1:297-318.
23. Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L. The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 2005, 38:404-415. 10.1016/j.jbi.2005.02.008, 16198999.
24. Weimar C, Holle DN, Benemann J, Schmid E, Schminke U, Haberl RL, Diener HC, Goertler M. Current management and risk of recurrent stroke in cerebrovascular patients with right-to-left cardiac shunt. Cerebrovasc Dis 2009, 28:349-356. 10.1159/000229553, 19628936.
25. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011, 305:822-823. 10.1001/jama.2011.163, 21343582.
26. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 2004, 23:2109-2123. 10.1002/sim.1802, 15211606.
27. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996, 15:361-387. 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4, 8668867.
28. Krasuski RA, Hart SA, Allen D, Qureshi A, Pettersson G, Houghtaling PL, Batizy LH, Blackstone E. Prevalence and repair of intraoperatively diagnosed patent foramen ovale and association with perioperative outcomes and long-term survival. JAMA 2009, 302:290-297. 10.1001/jama.2009.1012, 19602688.
29. Khattab AA, Windecker S, Juni P, Hildick-Smith D, Dudek D, Andersen HR, Ibrahim R, Schuler G, Walton AS, Wahl A, Mattle HP, Meier B. Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design. Trials 2011, 12:56. 10.1186/1745-6215-12-56, 3058012, 21356042.
30. Nedeltchev K, Arnold M, Wahl A, Sturzenegger M, Vella EE, Windecker S, Meier B, Mattle HP. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 2002, 72:347-350. 10.1136/jnnp.72.3.347, 1737790, 11861693.
31. Serena J, Marti-Fabregas J, Santamarina E, Rodriguez JJ, Perez-Ayuso MJ, Masjuan J, Segura T, Gallego J, Davalos A. Recurrent stroke and massive right-to-left shunt: results from the prospective Spanish multicenter (CODICIA) study. Stroke 2008, 39:3131-3136. 10.1161/STROKEAHA.108.521427, 18818401.
32. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liguori C, Brainin M, Homma S, Sacco RL. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke 1998, 29:944-948. 10.1161/01.STR.29.5.944, 9596240.
33. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002, 105:2625-2631. 10.1161/01.CIR.0000017498.88393.44, 12045168.
34. Casaubon L, McLaughlin P, Webb G, Yeo E, Merker D, Jaigobin C. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007, 34:74-80.